References
- Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999; 52(6): 1214-1220. https://doi.org/10.1212/WNL.52.6.1214
- Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, et al. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study. Am J Med Genet 1999; 88(6): 742-749. https://doi.org/10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#
- Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, et al. Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities. The Sicilian Neuro- Epidemiologic Study (SNES) Group. Neurology 1992; 42(10): 1901-1907. https://doi.org/10.1212/WNL.42.10.1901
- Wang SJ, Fuh JL, Liu CY, Lin KP, Chang R, Yih JS, et al. Parkinson's disease in Kin-Hu, Kinmen: A community survey by neurologists. Neuroepidemiology 1994; 13(1-2): 69-74. https://doi.org/10.1159/000110361
- MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123(Pt 4): 665-676. https://doi.org/10.1093/brain/123.4.665
- Newman EJ, Grosset KA, Grosset DG. Geographical difference in Parkinson's disease prevalence within West Scotland. Mov Disord 2009; 24(3): 401-406. https://doi.org/10.1002/mds.22359
- von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15(4): 473-490. https://doi.org/10.1016/j.euroneuro.2005.04.007
- Seo WK, Koh SB, Kim BJ, Yu SW, Park MH, Park KW, et al. Prevalence of Parkinson's disease in Korea. J Clin Neurosci 2007; 14(12): 1155-1157. https://doi.org/10.1016/j.jocn.2006.09.005
- Rare Disease Center, Korea Centers for Disease Prevention and Control. Genetic and rare disease statistics. [cited 2009 Sep 1]; Available from: URL:http://helpline.cdc.go.kr/web/ download/download_view.html-idx=252& bname= cyber&cate_idx=0000000003. (Korean)
- Park J, Yoo CI, Sim CS, Kim JW, Yi Y, Shin YC, et al. A retrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology 2006; 27(3): 445- 449. https://doi.org/10.1016/j.neuro.2006.01.005
- Tanner CM, Gilley DW, Goetz CG. A brief screening questionnaire for parkinsonism. Ann Neurol 1990; 28: 267- 268.
- Duarte J, Claveria LE, de Pedro-Cuesta J, Sempere AP, Coria F, Calne DB. Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity. Mov Disord 1995; 10(5): 643-649. https://doi.org/10.1002/mds.870100518
- Mutch WJ, Smith WC, Scott RF. A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991; 10(3): 150-156. https://doi.org/10.1159/000110261
- Jhoo JH, Kim KW, Lee DY, Youn JC, Lee TJ, Choo IH, et al. Comparison of the performance in two different Korean versions of mini-mental state examination: MMSE-KC and K-MMSE. J Korean Neuropsychiatr Assoc 2005; 44(1): 98-104. (Korean)
- Yang DW, Cho B, Chey JY, Kim SY, Kim BS. The development and validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc 2002; 20(2): 135-141. (Korean)
- Taylor KS, Counsell CE, Harris CE, Gordon JC. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism Related Disord 2006; 12(2): 79-85. https://doi.org/10.1016/j.parkreldis.2005.08.005
- Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med 2005; 37(5): 360-363.
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33(1): 159-174. https://doi.org/10.2307/2529310
- Yip CW, Tan EK. Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease. Mov Disord 2008; 23(7): 1032-1036. https://doi.org/10.1002/mds.21627
- Sarangmath N, Rattihalli R, Ragothaman M, Gopalkrishna G, Doddaballapur S, Louis ED, et al. Validity of a modified Parkinson's disease screening questionnaire in India: Effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries. Mov Disord 2005; 20(12): 1550- 1556. https://doi.org/10.1002/mds.20576
- Chan DK, Hung WT, Wong A, Hu E, Beran RG. Validating a screening questionnaire for parkinsonism in Australia. J Neurol Neurosurg Psychiatry 2000; 69(1): 117-120. https://doi.org/10.1136/jnnp.69.1.117
- Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology 2006; 27(3): 357-361. https://doi.org/10.1016/j.neuro.2005.11.005
- Nicoletti A, Salemi G, Morgante L, Le Pira F, Epifanio A, Reggio A, et al. A screening instrument for a Sicilian neuroepidemiological survey in the elderly. Arch Gerontol Geriatr 2004; 38(1): 37-44. https://doi.org/10.1016/S0167-4943(03)00081-5
- Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J Med Genet 1999; 88(5): 539- 543. https://doi.org/10.1002/(SICI)1096-8628(19991015)88:5<539::AID-AJMG19>3.0.CO;2-S
Cited by
- Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review vol.14, pp.1, 2010, https://doi.org/10.1186/1471-2458-14-653
- Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia vol.15, pp.8, 2010, https://doi.org/10.30773/pi.2018.06.02
- Validation of a Questionnaire for Distinguishing X-Linked Dystonia Parkinsonism From Its Mimics vol.9, pp.None, 2010, https://doi.org/10.3389/fneur.2018.00830